Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML

For most acute myeloid leukemia (AML) patients, an allogeneic hematopoietic stem cell transplantation (HSCT) offers the highest chance of sustained remissions and long-term survival. At diagnosis, high expression of the AML-associated genes BAALC (brain and acute leukemia, cytoplasmic) and MN1 (meni...

Descripción completa

Detalles Bibliográficos
Autores principales: Jentzsch, Madlen, Bill, Marius, Grimm, Juliane, Brauer, Dominic, Backhaus, Donata, Goldmann, Karoline, Schulz, Julia, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481166/
https://www.ncbi.nlm.nih.gov/pubmed/32862286
http://dx.doi.org/10.1007/s00277-020-04235-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481166/
https://www.ncbi.nlm.nih.gov/pubmed/32862286
http://dx.doi.org/10.1007/s00277-020-04235-8

Ejemplares similares